The new technique has an advantage over conventional pulse oximetry, which cannot detect methemoglobin. According to Steven L. Shafer, MD, editor-in-chief of Anesthesia & Analgesia, prior to the development of CO-oximetry, methemoglobinemia was nearly invisible in the OR.
Pulse CO-oximetry uses several different light wavelengths to assess methemoglobin levels, along with several other measures. In the study, 12 health volunteers were given sodium nitrite to raise their methemoglobin levels, then levels were monitored using the pulse CO-oximeter. The results were compared with measurements made directly in blood samples, and the pulse CO-oximeter provided “acceptable accurate” at monitoring levels.
Read the Newswise report on the study on pulse CO-oximetry.
Read more on anesthesia:
–Anesthesiologist Wins Maryland House Seat
–5 Reasons Anesthesiologists Will Cancel an ASC Case
–Study: Noninvasive Electrical Stimulation Reduces Patient Care
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.